A unique med-tech venture studio providing a suite of facilities and expert services that are flexible and responsive to the demands of the early-stage innovation and commercialization process. The founders (Suresh Pai and Celso Bagaoisan) have a successful track record of capital efficient product development from concept to commercialization.Website: www.lamamed.solutions

Band of Angels is Silicon Valley's oldest angel investment group.

Startup developing novel, minimally invasive surgical access instruments.++https://www.businesswire.com/news/home/20231212064812/en/Xpan-secures-FDA-510-k-clearance-and-announces-successful-completion-of-initial-human-clinical-cases-in-the-United-States++

Privately held medical device developer of Lava® LES, the FIRST liquid embolic product approved by FDA for use in the peripheral vasculature.++ https://www.prnewswire.com/news-releases/blackswan-vascular-wins-fda-premarket-approval-of-innovative-new-treatment-for-peripheral-arterial-hemorrhages-301800791.html ++++ https://www.prnewswire.com/news-releases/sirtex-medical-announces-strategic-investment-in-blackswan-vascular-inc-301189119.html ++++Acquired by Sirtex Medical in April 2023++

Abscess Drainage Technologies++Acquired by Merit Medical Systems Inc. (MMSI) in 2016++

Development and commercialization of innovative biomaterial and device solutions focused on improving the lives of patients suffering ear, nose, and throat (ENT) disorders. The Company's lead product XeroGel, was a novel hemostatic, resorbable nasal/epistaxis packing ++ Acquired by Entellus Medical (NASDAQ: ENTL) in 2016 and subsequently acquired by Stryker (NYSE: SYK) in 2018 ++Website: www.cogent-tx.com

Development and commercialization of the Gator Polymeric Ligation System.++ Acquired by Teleflex Medical, Inc. (NYSE: TFX) in August 2015 ++https://www.marketscreener.com/quote/stock/TELEFLEX-INCORPORATED-14582/news/Teleflex-Incorporated-acquired-certain-assets-of-Atsina-Surgical-LLC-38208515/

Development and commercialization of the EFx family of laparoscopic fascial closure system products.++ Acquired by Teleflex Medical, Inc. (NYSE: TFX) in May 2012 ++http://www.rttnews.com/1872874/teleflex-agrees-to-buy-axiom-technology-partners-llc-quick-facts.aspx++Awarded 2012 Innovation of the Year by Society of Laparoscopic Surgeons++http://finance.yahoo.com/news/teleflex-wins-award-innovation-204434761.html++Awarded the Excellence in Surgical Products Award by Surgical Products Magazine++http://www.reuters.com/article/2012/10/24/idUS100780+24-Oct-2012+BW20121024

General management and oversight of a venture-backed medical device company focused on novel stenting technologies used for treatment of aorto-ostial lesions.

Co-inventor of ACI's next generation femoral closure technology called the Mynx Vascular Closure Device. The product has been well received in the US market having been implanted in over 2M patients to date generating cumulative gross revenue in excess of $500M.++Acquired by Cardinal Health in May 2014 ++http://www.nasdaq.com/article/cardinal-health-closes-320-mln-acquisition-of-accessclosure-20140512-00897

Program Director overseeing the overall carotid therapeutic area/business for Boston Scientific Corporation (i.e. interventional device solutions for carotid disease).

Project Leader on key developmental activities involving covered and non-­covered implantable metallic stents for peripheral vascular indications.++ Acquired by Johnson and Johnson in 1996 ++

Lead Project Engineer developing proprietary delivery and balloon catheters for deployment and anchoring of unique ePTFE covered stent grafts for treatment of abdominal and thoracic aortic aneurysmal disease.++ Acquired by W.L. Gore & Associates in June, 1997 ++

Research and Development of novel plastic surgery implantables.